Metraipolis › archive › dc_22df7734b4ac

Anti-glycoprotein-210 antibodies — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-09T14:16:27.040Z
SHA-256 of the archived text
09bb7ae8b5277206d896128b96672f37f2a21bb36e652ea15f844a0a0860ccdb
Stable URL of this page
https://metraipolis.com/documento/dc_22df7734b4ac

How to cite

Anti-glycoprotein-210 antibodies — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_22df7734b4ac (Metraipolis archive dc_22df7734b4ac, sha256 09bb7ae8b5277206d896128b96672f37f2a21bb36e652ea15f844a0a0860ccdb)
BibTeX
@misc{dc22df7734b4ac,
  title = {Anti-glycoprotein-210 antibodies — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_22df7734b4ac; sha256 09bb7ae8b5277206d896128b96672f37f2a21bb36e652ea15f844a0a0860ccdb},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Anti-glycoprotein-210 antibodies (AGPA, anti-gp210, anti-nup210, anti-np210) are directed at gp210 and are found within primary biliary cirrhosis (PBC) patients in high frequency. AGPA recognize the cytoplasmic-oriented carboxyl terminus (tail) of the protein. While AGPA is found as a prognostic marker in only a minority of PBC patients, those that did had higher mortality and were predicted a poor outcome. In addition, patients that responded to ursodeoxycholic acid (UDCA) therapy and, therefore, had AGPA reductions failed to develop end-stage liver disease relative to untreated cohort with anti-gp210 Ab. PBC patients with potentially destructive AGPA have increased expression of Nup210 in the bile duct, a potential immune tolerance-escaping factor. Anti-mitochondrial, anti-centromere and anti-p62 antibodies are also found in (PBC). While patients with AGPA progress toward end-stage liver failure, patients with anti-centromere antibodies often progress toward portal hypertension, further indicating a specific role of the AGPA in PBC.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Anti-glycoprotein-210 antibodies» — https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies
Wikidata Q4774370 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4774370
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Anti-glycoprotein-210_antibodies?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1179399809, consultata il 2026-11-09T14:12:43.880Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: b53c56a30dcb8d9822b10d167e770ea88842f27c7faf4aced69bf916dfef7992